🎉 M&A multiples are live!
Check it out!

Zhejiang Huahai Valuation Multiples

Discover revenue and EBITDA valuation multiples for Zhejiang Huahai and similar public comparables like Pharming, Julphar, and Benevolent AI.

Zhejiang Huahai Overview

About Zhejiang Huahai

Zhejiang Huahai Pharmaceutical Co Ltd is engaged in Research & Development, production and sales of multi-dosage preparations, biological drugs, innovative drugs and specialty APIs.


Founded

2001

HQ

China
Employees

2.9K+

Website

huahaipharm.com

Financials

LTM Revenue $1.4B

LTM EBITDA $395M

EV

$3.7B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Zhejiang Huahai Financials

Zhejiang Huahai has a last 12-month revenue of $1.4B and a last 12-month EBITDA of $395M.

In the most recent fiscal year, Zhejiang Huahai achieved revenue of $1.1B and an EBITDA of $291M.

Zhejiang Huahai expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Zhejiang Huahai valuation multiples based on analyst estimates

Zhejiang Huahai P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.1B $1.3B XXX XXX XXX
Gross Profit $549M $710M XXX XXX XXX
Gross Margin 48% 53% XXX XXX XXX
EBITDA $291M $377M XXX XXX XXX
EBITDA Margin 25% 28% XXX XXX XXX
Net Profit $67.2M $161M XXX XXX XXX
Net Margin 6% 12% XXX XXX XXX
Net Debt $404M $643M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Zhejiang Huahai Stock Performance

As of April 15, 2025, Zhejiang Huahai's stock price is CNY 14 (or $2).

Zhejiang Huahai has current market cap of CNY 21.7B (or $3.0B), and EV of CNY 27.1B (or $3.7B).

See Zhejiang Huahai trading valuation data

Zhejiang Huahai Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$3.7B $3.0B XXX XXX XXX XXX $0.12

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Zhejiang Huahai Valuation Multiples

As of April 15, 2025, Zhejiang Huahai has market cap of $3.0B and EV of $3.7B.

Zhejiang Huahai's trades at 2.7x LTM EV/Revenue multiple, and 9.4x LTM EBITDA.

Analysts estimate Zhejiang Huahai's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Zhejiang Huahai and 10K+ public comps

Zhejiang Huahai Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $3.7B XXX XXX XXX
EV/Revenue 2.8x XXX XXX XXX
EV/EBITDA 9.9x XXX XXX XXX
P/E 17.3x XXX XXX XXX
P/E/Growth 1.2x XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Zhejiang Huahai Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Zhejiang Huahai Valuation Multiples

Zhejiang Huahai's NTM/LTM revenue growth is 13%

Zhejiang Huahai's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Zhejiang Huahai's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Zhejiang Huahai's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Zhejiang Huahai and other 10K+ public comps

Zhejiang Huahai Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 17% XXX XXX XXX XXX
EBITDA Margin 28% XXX XXX XXX XXX
EBITDA Growth 30% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 41% XXX XXX XXX XXX
Revenue per Employee $0.4M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 14% XXX XXX XXX XXX
G&A Expenses to Revenue 7% XXX XXX XXX XXX
R&D Expenses to Revenue 12% XXX XXX XXX XXX
Opex to Revenue 42% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Zhejiang Huahai Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Zhejiang Huahai M&A and Investment Activity

Zhejiang Huahai acquired  XXX companies to date.

Last acquisition by Zhejiang Huahai was  XXXXXXXX, XXXXX XXXXX XXXXXX . Zhejiang Huahai acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Zhejiang Huahai

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Zhejiang Huahai

When was Zhejiang Huahai founded? Zhejiang Huahai was founded in 2001.
Where is Zhejiang Huahai headquartered? Zhejiang Huahai is headquartered in China.
How many employees does Zhejiang Huahai have? As of today, Zhejiang Huahai has 2.9K+ employees.
Is Zhejiang Huahai publicy listed? Yes, Zhejiang Huahai is a public company listed on SHG.
What is the stock symbol of Zhejiang Huahai? Zhejiang Huahai trades under 600521 ticker.
When did Zhejiang Huahai go public? Zhejiang Huahai went public in 2003.
Who are competitors of Zhejiang Huahai? Similar companies to Zhejiang Huahai include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Zhejiang Huahai? Zhejiang Huahai's current market cap is $3.0B
What is the current revenue of Zhejiang Huahai? Zhejiang Huahai's last 12-month revenue is $1.4B.
What is the current EBITDA of Zhejiang Huahai? Zhejiang Huahai's last 12-month EBITDA is $395M.
What is the current EV/Revenue multiple of Zhejiang Huahai? Current revenue multiple of Zhejiang Huahai is 2.7x.
What is the current EV/EBITDA multiple of Zhejiang Huahai? Current EBITDA multiple of Zhejiang Huahai is 9.4x.
What is the current revenue growth of Zhejiang Huahai? Zhejiang Huahai revenue growth between 2023 and 2024 was 17%.
Is Zhejiang Huahai profitable? Yes, Zhejiang Huahai is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.